Warhound — Company Profile & Funding History

Product

The Texas-based company combines licensed Colossal Biosciences technology with training and animal care. Anduril supplies complementary equipment and software for dogs and their handlers.

CEO David Spirk leads the programme, which aims to improve domestic supply and reduce dependence on overseas breeders. American Humane Society will support training certification and retirement arrangements.

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Oct 22, 2026	Seed	$200M	8VC — ParticipantARK Invest — ParticipantBreyer Capital — ParticipantBuilders VC — ParticipantCAZ Investments — ParticipantFranklin Templeton — ParticipantIn-Q-Tel — ParticipantLux Capital — ParticipantNeogenesis — ParticipantRobert Nelsen — ParticipantSequoia Capital — ParticipantUS Innovative Technology Fund (USIT) — Participant

Investors

8VCJoined Seed ARK InvestJoined Seed Breyer CapitalJoined Seed Builders VCJoined Seed CAZ InvestmentsJoined Seed Franklin TempletonJoined Seed In-Q-TelJoined Seed Lux CapitalJoined Seed NeogenesisJoined Seed Robert NelsenJoined Seed Sequoia CapitalJoined Seed US Innovative Technology Fund (USIT)Joined Seed

Coverage

Oct 22, 2026Warhound · Seed

Similar companies

SEGNOSSEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.Undisclosed · Pre-Series A

Warp SciencesWarp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.$215M · Series A

KinishRice-based dairy alternatives and plant molecular-farming technology.¥490M · Series A first close

Sources

prnewswire.com ↗